Simultaneous Separation and Determination of Isosorbide Dinitrate and Isosorbide 5-Mononitrate in Human Plasma by LC–MS–MS

被引:3
作者
Hohyun Kim
Jae-Yong Lee
Ki-Seob Song
Young-Hwan Seo
So-Young Park
Kyeong-Ho Kim
Hyun Dong Je
Sang Beom Han
Ji Hoon Jeong
机构
[1] Chung-Ang University,College of Pharmacy
[2] Kangwon National University,College of Pharmacy
[3] Chung-Ang University,Department of Pharmacology, College of Medicine
[4] Seoul Pharma Laboratories Co. Ltd. (SPL),Department of Drug Development Supporting Division
[5] Korea University,Environmental Toxico
[6] Catholic University of Daegu,Genomic and Proteomic Center, College of Medicine
来源
Chromatographia | 2010年 / 71卷
关键词
Column liquid chromatography; Tandem mass spectrometry; Pharmacokinetic study; Isosorbide dinitrate and isosorbide 5-mononitrate;
D O I
暂无
中图分类号
学科分类号
摘要
A sensitive, selective, and simple liquid chromatography-tandem mass spectrometry method has been developed for the simultaneous separation and determination of isosorbide dinitrate and its active metabolite, isosorbide 5-mononitrate, in human plasma. Topiramate was used as the internal standard. Sample preparation consisted of a simple one-step liquid–liquid extraction with ethylacetate without pH adjustment. The method was fully validated with respect to linearity, sensitivity, specificity, recovery, accuracy, and precision. Isosorbide dinitrate and isosorbide 5-mononitrate were stable in standard solution and in plasma samples under storage and processing conditions. The assay was successfully applied to the pharmacokinetic study of isosorbide dinitrate and isosorbide 5-mononitrate in human plasma.
引用
收藏
页码:595 / 602
页数:7
相关论文
共 51 条
[1]  
Berlin R(1987)undefined Drugs 33 1-4
[2]  
Jonsson UE(1987)undefined Drugs 33 23-31
[3]  
Nyberg G(1994)undefined Am J Ther 1 93-101
[4]  
Pommier F(1996)undefined J Chromatogr B 678 354-359
[5]  
Gauducheam N(2004)undefined J Chromatogr B 800 271-274
[6]  
Pineau V(1995)undefined J Chromatogr B 663 153-159
[7]  
Sioufi A(2002)undefined Eur J Pharm Biopharm 53 49-56
[8]  
Godbillon J(2004)undefined Int J Clin Pharmacol Ther 42 463-472
[9]  
Pastera J(2006)undefined J Chromatogr B 832 302-306
[10]  
Vyslouzil L(2007)undefined J Chromatogr B Analyt Technol Biomed Life Sci 846 323-328